within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02A_Antacids.A02AA01_MagnesiumCarbonate;

model MagnesiumCarbonate
  extends Pharmacolibrary.Drugs.ATC.A.A02AA01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A02AA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Magnesium carbonate is an inorganic compound used mainly as a magnesium supplement to treat magnesium deficiency, dyspepsia, and as an antacid for the relief of indigestion and heartburn. It is approved for use as an over-the-counter antacid and laxative, but it is not commonly used in hospitals for acute hypomagnesemia due to slow absorption.</p><h4>Pharmacokinetics</h4><p>Estimated oral pharmacokinetic parameters for healthy adult individuals, as no literature reports detailed PK studies for magnesium carbonate as a drug. Parameters inferred from general knowledge of oral magnesium salt absorption.</p><h4>References</h4><ol><li><p>Kim, KS, et al., &amp; Choi, HG (2016). Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer. <i>Archives of pharmacal research</i> 39(4) 531–538. DOI:<a href=\"https://doi.org/10.1007/s12272-015-0701-9\">10.1007/s12272-015-0701-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26992922/\">https://pubmed.ncbi.nlm.nih.gov/26992922</a></p></li><li><p>Aideloje, SO, et al., &amp; Ugwu, NC (1998). Altered pharmacokinetics of halofantrine by an antacid, magnesium carbonate. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 46(3) 299–303. DOI:<a href=\"https://doi.org/10.1016/s0939-6411(98)00029-0\">10.1016/s0939-6411(98)00029-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9885302/\">https://pubmed.ncbi.nlm.nih.gov/9885302</a></p></li><li><p>Zardán Gómez de la Torre, T, et al., &amp; Strømme, M (2022). Bioavailability of Celecoxib Formulated with Mesoporous Magnesium Carbonate-An In Vivo Evaluation. <i>Molecules (Basel, Switzerland)</i> 27(19) –. DOI:<a href=\"https://doi.org/10.3390/molecules27196188\">10.3390/molecules27196188</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36234733/\">https://pubmed.ncbi.nlm.nih.gov/36234733</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end MagnesiumCarbonate;
